1. Home
  2. GV vs HCWB Comparison

GV vs HCWB Comparison

Compare GV & HCWB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Visionary Education Technology Holdings Group Inc.

GV

Visionary Education Technology Holdings Group Inc.

HOLD

Current Price

$1.40

Market Cap

5.9M

Sector

Real Estate

ML Signal

HOLD

Logo HCW Biologics Inc.

HCWB

HCW Biologics Inc.

HOLD

Current Price

$1.84

Market Cap

5.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GV
HCWB
Founded
2013
2018
Country
Canada
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.9M
5.5M
IPO Year
2022
2021

Fundamental Metrics

Financial Performance
Metric
GV
HCWB
Price
$1.40
$1.84
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$35.00
AVG Volume (30 Days)
109.8K
151.3K
Earning Date
12-26-2025
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$7,773,905.00
$422,026.00
Revenue This Year
N/A
$178.64
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.02
$1.52
52 Week High
$9.60
$41.20

Technical Indicators

Market Signals
Indicator
GV
HCWB
Relative Strength Index (RSI) 46.30 33.18
Support Level $1.43 $1.52
Resistance Level $1.48 $2.15
Average True Range (ATR) 0.09 0.18
MACD 0.01 0.05
Stochastic Oscillator 51.29 46.04

Price Performance

Historical Comparison
GV
HCWB

About GV Visionary Education Technology Holdings Group Inc.

Visionary Holdings Inc is a private education providing company located in Canada, with subsidiaries in Canada and market partners in China, that offers high-quality education resources to students around the globe. The company aims to provide access to secondary, college, undergraduate and graduate, and vocational education to students in Canada through technological innovation so that more people can learn, grow, and succeed to their full potential. As a fully integrated provider of educational programs and services in Canada, the company has been serving and will continue to serve both Canadian and international students.

About HCWB HCW Biologics Inc.

HCW Biologics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen the health span by disrupting the link between chronic, low-grade inflammation and age-related diseases. The company has developed TOBI discovery platform, or Tissue factor-based fusion discovery platform, for the design of category-defining immunotherapeutic drugs. It has selected two molecules as its product candidate; HCW9218 and HCW9302. HCW9218 is a bifunctional immunotherapeutic designed with the capabilities to neutralize transforming growth and stimulate immune cells. HCW9302 is designed to activate and expand regulatory T cells, which deactivate inflammasomes.

Share on Social Networks: